PRL-3 Inhibitor is a cell-permeable benzylidene rhodanine compound that potently inhibits PRL-3 (hPRL-3), a member of the regenerating liver family tyrosine phosphatases. PRL-3 Inhibitor has been shown to reduce the invasiveness of murine melanoma B16F10 cells.
1. Ahn, J.H., et al. 2006. Bioorg. Med. Chem. Lett. 16: 2996-2999. PMID: 16530413
Soluble in DMSO (5 mg/ml). Slight warming may be necessary for complete solubilization.
Store at -20° C
268.90° C (Predicted)
620.54° C (Predicted)
1.86 g/cm3 (Predicted)
n20D 1.77 (Predicted)
hPRL-3 : IC50 = 900 nM
pKa: 7.11 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
AhnAhn, JH. et al. (PubMed 16530413) investigated the ability of several of rhodanine derivatives to inhibit PRL-3. They found that 1-(2-Bromobenzyloxy)-4-bromo-2-benzylidene rhodanine showed a significant ability to inhibit PRL-3. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn